Recap: Eagle Pharmaceuticals Q3 Earnings


Eagle Pharmaceuticals EGRX reported its Q3 earnings results on Monday, November 7, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.


Eagle Pharmaceuticals beat estimated earnings by 23.08%, reporting an EPS of $1.12 versus an estimate of $0.91.

Revenue was up $26.05 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $1.8 which was followed by a 5.05% drop in the share price the next day.

Here's a look at Eagle Pharmaceuticals's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 3.36 3.88 0.94 0.83
EPS Actual 1.56 4.04 0.85 0.56
Revenue Estimate 116.89M 123.33M 51.08M 46.40M
Revenue Actual 74.14M 115.87M 42.32M 39.85M

To track all earnings releases for Eagle Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!